LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink skin cancer before surgery
Disease control Not yet recruitingThis phase 2 trial tests two drugs, cemiplimab and cetuximab, given before surgery to people with advanced skin cancer that is hard to remove. The goal is to shrink the tumor enough to make surgery easier or even unnecessary. The study will enroll 27 participants across three sit…
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Melanoma and Skin Cancer Trials Limited • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New injection combo takes aim at tough skin cancers
Disease control Not yet recruitingThis phase 2 trial tests a combination of two immune-boosting drugs, L19IL2 and L19TNF, injected directly into skin tumors. It is for people with advanced cutaneous squamous cell carcinoma whose cancer has worsened despite or who cannot tolerate standard immunotherapy. Up to 92 p…
Matched conditions: LOCALLY ADVANCED CUTANEOUS SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC